Subclinical thyroid disease

American Journal of Medicine

Volumn 100, Issue 2, 1996, Pages 217-223

  Surks, Martin I ^a,b   Ocampo, Enrico ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ARTICLE; BONE METABOLISM; CLINICAL FEATURE; HEART FUNCTION; HORMONE DETERMINATION; HUMAN; HYPERLIPIDEMIA; HYPERTHYROIDISM; HYPOTHYROIDISM; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0030060216     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)89462-4     Document Type: Article

References (5)

1. Duncan WE, Chang A, Solomon B, Wartofsky L. Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone. Thyroid. 1994;4:183-190.
2. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol. 1994;130:350-356.
3. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. NEJM. 1994;331: 1249-1252.
4. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA. 1995;273:808-812.
5. Surks MI, Chopra IJ, Mariash CN, et al. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA. 1990;263:1529-1532.